AR198064A1 - Sintesis de nuevos derivados del del acido heterociclico-indol-3-il-carboxilico - Google Patents

Sintesis de nuevos derivados del del acido heterociclico-indol-3-il-carboxilico

Info

Publication number
AR198064A1
AR198064A1 AR244863A AR24486372A AR198064A1 AR 198064 A1 AR198064 A1 AR 198064A1 AR 244863 A AR244863 A AR 244863A AR 24486372 A AR24486372 A AR 24486372A AR 198064 A1 AR198064 A1 AR 198064A1
Authority
AR
Argentina
Prior art keywords
indol
carboxyl
synthesis
new derivatives
heterocyclic acid
Prior art date
Application number
AR244863A
Other languages
English (en)
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of AR198064A1 publication Critical patent/AR198064A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AR244863A 1971-11-03 1972-10-27 Sintesis de nuevos derivados del del acido heterociclico-indol-3-il-carboxilico AR198064A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1811672A GB1356834A (en) 1971-11-03 1971-11-03 Indole derivatives
GB1811672 1972-04-19
GB3076772 1972-06-30

Publications (1)

Publication Number Publication Date
AR198064A1 true AR198064A1 (es) 1974-05-31

Family

ID=27257588

Family Applications (3)

Application Number Title Priority Date Filing Date
AR244863A AR198064A1 (es) 1971-11-03 1972-10-27 Sintesis de nuevos derivados del del acido heterociclico-indol-3-il-carboxilico
AR249382A AR203627A1 (es) 1971-11-03 1973-07-31 Sintesis de nuevos derivados del acido heterociclico-indol-3-ilacetico
AR249381A AR203626A1 (es) 1971-11-03 1973-07-31 Sintesis de nuevos acidos heterociclico-indol-3-ii-acetic

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR249382A AR203627A1 (es) 1971-11-03 1973-07-31 Sintesis de nuevos derivados del acido heterociclico-indol-3-ilacetico
AR249381A AR203626A1 (es) 1971-11-03 1973-07-31 Sintesis de nuevos acidos heterociclico-indol-3-ii-acetic

Country Status (17)

Country Link
US (1) US3884919A (OSRAM)
JP (1) JPS4856667A (OSRAM)
AR (3) AR198064A1 (OSRAM)
BE (1) BE790679A (OSRAM)
CA (1) CA983932A (OSRAM)
CH (1) CH577499A5 (OSRAM)
DD (1) DD105611A5 (OSRAM)
DE (1) DE2253927A1 (OSRAM)
EG (1) EG11358A (OSRAM)
ES (2) ES408226A1 (OSRAM)
FR (1) FR2158464B1 (OSRAM)
GB (1) GB1356834A (OSRAM)
HU (1) HU169711B (OSRAM)
IE (1) IE37998B1 (OSRAM)
IL (1) IL40521A (OSRAM)
NL (1) NL7214807A (OSRAM)
SE (1) SE384856B (OSRAM)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) * 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
FR2421900A1 (fr) * 1977-03-17 1979-11-02 Sauba Lab Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
US4316847A (en) * 1979-07-30 1982-02-23 Hoffmann-La Roche Inc. Pyrroles and pyrrolidines
US4459227A (en) * 1981-03-02 1984-07-10 Duke University Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones
EP0746554A1 (en) * 1994-02-23 1996-12-11 Pfizer Inc. 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents
US6252084B1 (en) * 1994-03-15 2001-06-26 Eli Lilly And Company 1H-indole-3-acetamide sPLA2 inhibitors
JP2002504541A (ja) * 1998-02-25 2002-02-12 ジェネティックス・インスチチュート・インコーポレーテッド ホスホリパーゼ酵素阻害剤
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
SE0200411D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
TW200307542A (en) * 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301010D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SE0301009D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
ATE316077T1 (de) 2003-04-25 2006-02-15 Actimis Pharmaceuticals Inc Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten
EP1618094B1 (en) * 2003-04-30 2007-09-05 The Institutes for Pharmaceutical Discovery, LLC Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1718649B1 (en) 2004-01-31 2009-06-10 Actimis Pharmaceuticals, Inc., Imidazo 1,2-c pyrimidinylacetic acid derivatives
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
ATE517085T1 (de) 2004-11-23 2011-08-15 Astrazeneca Ab Zur behandlung von atemwegserkrankungen geeignete phenoxyessigsäurederivate
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
US8148572B2 (en) 2005-10-06 2012-04-03 Astrazeneca Ab Compounds
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
US7741360B2 (en) 2006-05-26 2010-06-22 Astrazeneca Ab Bi-aryl or aryl-heteroaryl substituted indoles
EP2046740B1 (en) 2006-07-22 2012-05-23 Oxagen Limited Compounds having crth2 antagonist activity
UA100983C2 (ru) 2007-07-05 2013-02-25 Астразенека Аб Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
AU2008305633B2 (en) 2007-09-25 2013-09-12 Actimis Pharmaceuticals, Inc. 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
ATE547407T1 (de) 2007-09-25 2012-03-15 Actimis Pharmaceuticals Inc Alkylthiopyrimidine als crth2-antagonisten
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
NZ587251A (en) 2008-01-18 2011-12-22 Oxagen Ltd Indole derivatives having CRTH2 antagonist activity
EP2240444A1 (en) 2008-01-22 2010-10-20 Oxagen Limited Compounds having crth2 antagonist activity
WO2009093026A1 (en) 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
AU2019362753A1 (en) * 2018-10-05 2021-05-20 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (OSRAM) * 1963-06-06
US3679692A (en) * 1969-10-01 1972-07-25 Mead Johnson & Co Iminomethylindolines

Also Published As

Publication number Publication date
AR203627A1 (es) 1975-09-30
BE790679A (fr) 1973-04-27
IE37998B1 (en) 1977-12-07
IL40521A0 (en) 1972-12-29
NL7214807A (OSRAM) 1973-05-07
DD105611A5 (OSRAM) 1974-05-05
CH577499A5 (OSRAM) 1976-07-15
EG11358A (en) 1977-02-28
IE37998L (en) 1973-05-03
DE2253927A1 (de) 1973-05-10
JPS4856667A (OSRAM) 1973-08-09
GB1356834A (en) 1974-06-19
CA983932A (en) 1976-02-17
ES408226A1 (es) 1976-02-01
AR203626A1 (es) 1975-09-30
IL40521A (en) 1975-06-25
HU169711B (OSRAM) 1977-02-28
SE384856B (sv) 1976-05-24
US3884919A (en) 1975-05-20
ES437311A1 (es) 1977-04-01
FR2158464B1 (OSRAM) 1976-07-02
FR2158464A1 (OSRAM) 1973-06-15

Similar Documents

Publication Publication Date Title
AR198064A1 (es) Sintesis de nuevos derivados del del acido heterociclico-indol-3-il-carboxilico
IT972657B (it) Produzione di composti polifunzionali
SE401834B (sv) Forfarande for framstellning av furanforeningar
SE432102B (sv) Forfarande for framstellning av estrar av penicilliner
BE779128A (fr) Nouveaux derives de benzazine
NO137318C (no) Fremgangsm}te for kontinuerlig fremstilling av natriumperkarbonat
SE399423B (sv) Forfarande for framstellning av prostaglandinanaloger
BE787847R (fr) Tour de
FI55335B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-fluor-substituerade fenotiaziner
BE781873A (fr) Dirives de piperazine
BE791907A (fr) Nouveaux derives des imidazolines
BE792364A (fr) Derives de substitution du sulfonylglycolanilide
SE386678B (sv) Forfarande for framstellning av fluoranderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
FI55033B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva pyrazin-4-oxidderivat
JPS5459275A (en) Production of heterocyclic compound
SE415837B (sv) Forfarande for framstellning av 15-ketaler av prostaglandiner
BE786416A (fr) Production de tetramisoles
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
SE385482B (sv) Forfarande for framstellning av basiskt substituerade 3-bensoyl-benso(b)tiofen-derivat
BE777764A (fr) Production de composes de methyl-etain
SE401832B (sv) Forfarande for framstellning av derivat av 2-formyl-3-karbonamido-kinoxalin-di-n-oxider
SE384381B (sv) Forfarande for kontinuerlig framstellning av ferrokisel
SE402286B (sv) Forfarande for framstellning av substituerade isokinoliner
SE7808905L (sv) Forfarande for framstellning av biocyklisk forening